Clinical Trial Update: Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating chemotherapy with or without panitumumab for unresectable, locally advanced, or metastatic pancreatic cancer without KRAS mutation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer Ajcc V8
• Unresectable Pancreatic Adenocarcinoma

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 3 | Status: RECRUITING